June 16, 2017
The U.S. Securities and Exchange Commission has accused a maker of cannabis-based products and its CEO of inflating the value of the company's assets in connection with a supposedly $35 million acquisition, slapping them with a securities fraud suit in Nevada federal court on Thursday.